Analysis of Candidate Genes for Prostate Cancer

Considerable evidence demonstrates that genetic factors are important in the development and aggressiveness of prostate cancer. To identify genetic variants that predispose to prostate cancer we tested candidate SNPs from genomic regions that show linkage to prostate cancer susceptibility and/or aggressiveness, as well as genes that show a significant difference in mRNA expression level between tumor and normal tissue. Cases had histologically verified prostate cancer. Controls were at least 65 years old, never registered a PSA above 2.5 ng/ml, always had digital rectal examinations that were not suspicious for cancer, and have no known family history of prostate cancer. Thirty-nine coding SNPs and nine non-coding SNPs were tested in up to 590 cases and 556 controls resulting in over 40,000 SNP genotypes. Significant differences in allele frequencies between cases and controls were observed for ID3 (inhibitor of DNA binding), p = 0.05, HPN (hepsin), p = 0.009, BCAS1 (breast carcinoma amplified sequence 1), p = 0.007, CAV2 (caveolin 2), p = 0.007, EMP3 (epithelial membrane protein 3), p < 0.0001, and MLH1 (mutL homolog 1), p < 0.0001. SNPs in three of these genes (BCAS1, EMP3 and MLH1) remained significant in an age-matched subsample.

[1]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[2]  H. Lodish,et al.  Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*) , 1996, The Journal of Biological Chemistry.

[3]  Siavash Ghaffari,et al.  A candidate prostate cancer susceptibility gene at chromosome 17p , 2001, Nature Genetics.

[4]  D J Schaid,et al.  Evidence for a prostate cancer-susceptibility locus on chromosome 20. , 2000, American journal of human genetics.

[5]  J. Witte,et al.  Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. , 2001, American journal of human genetics.

[6]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[7]  D V Conti,et al.  Genomewide scan for prostate cancer-aggressiveness loci. , 2000, American journal of human genetics.

[8]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[9]  K. Kinzler,et al.  Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.

[10]  J. Stanford,et al.  Genetics of prostate cancer: too many loci, too few genes. , 2000, American journal of human genetics.

[11]  T. Beaty,et al.  Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Goode,et al.  A genomic scan of families with prostate cancer identifies multiple regions of interest. , 2000, American journal of human genetics.

[13]  J. Witte,et al.  Genome‐wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci , 2003, The Prostate.

[14]  P. Humphrey,et al.  Clinical and pathological features of hereditary prostate cancer. , 1996, The Journal of urology.

[15]  D. Kowbel,et al.  Characterization of the novel amplified in breast cancer-1 (NABC1) gene product. , 2003, Experimental cell research.

[16]  K. Lange,et al.  Programs for pedigree analysis: Mendel, Fisher, and dGene , 1988, Genetic epidemiology.

[17]  P. Peltomäki,et al.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer. , 2001, Human molecular genetics.

[18]  R. North,et al.  Epithelial Membrane Proteins Induce Membrane Blebbing and Interact with the P2X7 Receptor C Terminus* , 2002, The Journal of Biological Chemistry.

[19]  W. Catalona,et al.  Screening for prostate cancer in high risk populations. , 2002, The Journal of urology.

[20]  F. Leach.  Microsatellite instability and prostate cancer: clinical and pathological implications , 2002, Current opinion in urology.

[21]  A. Whittemore,et al.  Where are the prostate cancer genes?—A summary of eight genome wide searches , 2003, The Prostate.

[22]  M. Ittmann,et al.  Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. , 2001, Cancer research.

[23]  J. Witte,et al.  Replication linkage study for prostate cancer susceptibility genes , 2000, The Prostate.

[24]  J. Witte,et al.  A genome screen of multiplex sibships with prostate cancer. , 2000, American journal of human genetics.

[25]  A. Iavarone,et al.  Id proteins at the cross-road of development and cancer , 2001, Oncogene.

[26]  Yusuke Nakamura,et al.  A high-throughput SNP typing system for genome-wide association studies , 2001, Journal of Human Genetics.

[27]  J. Richie,et al.  Caveolin-1 Interacts with Androgen Receptor , 2001, The Journal of Biological Chemistry.

[28]  Jeffrey A. Magee,et al.  Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.

[29]  M. Boehnke,et al.  Allele frequency estimation from data on relatives. , 1991, American journal of human genetics.

[30]  T. Beaty,et al.  Fundamentals of Genetic Epidemiology , 1993 .

[31]  P. Humphrey,et al.  The early detection of prostate carcinoma with prostate specific antigen , 1997, Cancer.